Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: An evidence-based approach

Archives of Gynecology and Obstetrics

Volumn 285, Issue 6, 2012, Pages 1737-1745

  Hashim, Hatem Abu ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Aromatase inhibitors; Clomiphene citrate; Gonadotrophins; Intrauterine insemination; Laparoscopic ovarian diathermy; Metformin; Ovulation induction; Polycystic ovary syndrome

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; METFORMIN; RECOMBINANT FOLLITROPIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

DIATHERMY; DIET THERAPY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; EXERCISE; HUMAN; INSULIN RESISTANCE; INTRAUTERINE INSEMINATION; LAPAROSCOPIC OVARIAN DIATHERMY; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TERATOGENICITY; WEIGHT REDUCTION;

AROMATASE INHIBITORS; CLOMIPHENE; DIATHERMY; ESTROGEN ANTAGONISTS; FEMALE; GONADOTROPINS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84864479728     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2261-2     Document Type: Review

References (85)

1. Overbeek A, Lambalk CB (2009) Phenotypic and pharmacogenet-ic aspects of ovulation induction in WHO II anovulatory women. Gynecol Endocrinol 25:222-234. doi:10.1080/095135908025 71118
2. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E (2009) Clo-miphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev (4):CD002249. doi:10.1002/14651 858.CD002249.pub4
3. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic proWle. J Clin Endocrinol Metab 84:4006-4011. doi:10.1210/jc.84.11.4006
4. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078- 3082. doi:10.1210/jc.83.9.3078
5. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Esco-bar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438. doi:10.1210/jc.85.7.2434
6. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749. doi:10.1210/jc.2003-032046
7. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544-551. doi:10.1093/humrep/ dep399
8. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89:505-522. doi:10.1016/j.fertnstert.2007.09.041
9. Vause TD, Cheung AP, Sierra S, Society of Obstetricians and Gynaecologists of Canada et al (2010) Ovulation induction in polycystic ovary syndrome: no. 242, May 2010. Int J Gynaecol Obstet 111:95-100. doi:10.1016/j.ijgo.2010.07.001
10. Homburg R (2005) Clomiphene citrate-end of an era? A mini-review. Hum Reprod 20:2043-2051. doi:10.1093/humrep/dei042
11. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (2002) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77:91-97. doi:10.1016/S0015-0282(01)02929-6
12. Messinis IE (2005) Ovulation induction: a mini review. Hum Re-prod 20:2688-2697. doi:10.1093/humrep/dei128
13. National Collaborating Centre for Women's and Children's Health/National Institute for Clinical Excellence (2004) Fertility: assessment and treatment for people with fertility problems. Clinical Guideline No. 11. RCOG Press, London. http://www.nice. org.uk/nicemedia/pdf/CG011niceguideline.pdf
14. Amer SAK (2008) Laparoscopic ovarian surgery for polycystic ovarian syndrome. In: Dunlop W, Ledger WL (eds) Recent advances in obstetrics and gynaecology, 24th edn. Royal Society of Medicine Press Ltd, London, pp 227-243
15. Legro RS, Barnhart HX, SchlaV WD, Cooperative Multicenter Reproductive Medicine Network et al (2007) Clomiphene, metfor-min, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551-566
16. Gonen Y, Casper RF (1990) Sonographic determination of a possible adverse eVect of clomiphene citrate on endometrial growth. Hum Reprod 5:670-674
17. Opsahl MS, Robins ED, O'Connor DM, Scott RT, Fritz MA (1996) Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 66:533-539
18. Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H (1997) EVects of CC on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67:256-260. doi:10.1016/S0015-0282(97)81907-3
19. Dehbashi S, Parsanezhad ME, Alborzi S, Zarei A (2003) EVect of clomiphene citrate on endometrium thickness and echogenic patterns. Int J Gynecol Obstet 80:49-53. doi:10.1016/S0020-7292 (02)00341-7
20. Randall JM, Templeton A (1991) Cervical mucus score and in vitro sperm mucus interaction in spontaneous and CC citrate cycles. Fertil Steril 56:465-468
21. Shoham Z, Borenstein R, Lunenfeld B, Pariente C (1990) Hormonal proWles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol (Oxf) 33:271-278. doi:10.1111/j.1365-2265.1990.tb00491.x
22. Imani B, Eijkemans MJC, te Velde ER, Habbema JD, Fauser BC (1998) Predictors of patients remaining anovulatory during clomi-phene citrate induction of ovulation in normogonadotropic oli-goamenorrheic infertility. J Clin Endocrinol Metab 83:2361-2365. doi:10.1210/jc.83.7.2361
23. Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Gi-udice LC, Fauser BC (2000) Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 85:676- 682. doi:10.1210/jc.85.2.676
24. Parsanezhad ME, Alborzi S, Zarei A, Dehbashi S, Omrani G (2001) Insulin resistance in clomiphene responders and nonre-sponders with polycystic ovarian disease and therapeutic eVects of metformin. Int J Gynaecol Obstet 75:43-50. doi:10.1016/S0020-7292(01)00470-2
25. Overbeek A, Kuijper EA, Hendriks ML et al (2009) Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 24:2007-2013. doi:10.1093/humrep/dep114
26. Padmanabhan V (2009) Polycystic ovary syndrome-"A Riddle Wrapped in a Mystery inside an Enigma". J Clin Endocrinol Metab 94:1883-1885. doi:10.1210/jc.2009-0492
27. Reefhuis J, Honein MA, Schieve LA, Rasmussen SA, National Birth Defects Prevention Study (2011) Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997- 2005. Hum Reprod 26:451-457. doi:10.1093/humrep/deq313
28. Al-Azemi M, Omu FE, Omu AE (2004) The eVect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 270:205-210. doi:10.1007/s00404-003-0537-2
29. Norman RJ, Noakes M, Wu R, Davies MJ, Moran L, Wang JX (2004) Improving reproductive performance in overweight/obese women with eVective weight management. Hum Reprod Update 10:267-280. doi:10.1093/humupd/dmh018
30. Norman RJ, Davies MJ, Lord J, Moran LJ (2002) The role of lifestyle modiWcation in polycystic ovary syndrome. Trends Endocri-nol Metab 13:251-257. doi:10.1016/S1043-2760(02)00612-4
31. Hoeger KM (2007) Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol 50:277-294. doi:10.1097/GRF.0b013e31802f54c8
32. Pasquali R, Gambineri A, Pagotto U (2006) The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 113:1148-1159. doi:10.1111/j.1471-0528.2006.00990.x
33. Tolino A, Gambardella V, Caccavale C et al (2005) Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 119:87-93. doi:10.1016/j.ejogrb.2004. 06.043
34. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ (2009) Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 92:1966-1982. doi:10.1016/j.fertnstert. 2008.09.018
35. Moran LJ, Hutchison SK, Norman RJ, Teede HJ (2011) Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2):CD007506. doi:10.1002/14651858. CD007506.pub2
36. Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS (2004) A randomized trial of the eVects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 81:630-637. doi:10.1016/j.fertnstert.2003.08.023
37. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ (2003) Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:812-819. doi:10.1210/jc.2002-020815
38. Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA (2000) EVects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J Clin Endocrinol Metab 85:2463-2468. doi:10.1210/jc.85.7.2463
39. Palomba S, Falbo A, Giallauria F et al (2010) Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Hum Reprod 25:2783-2791. doi:10.1093/humrep/deq254
40. Otta CF, Wior M, Iraci GS et al (2010) Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Gynecol Endocrinol 26:173-178. doi:10.3109/09513590903215581
41. Karimzadeh MA, Javedani M (2010) An assessment of lifestyle modiWcation versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril 94:216-220. doi:10.1016/j.fertnstert.2009.02.078
42. Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF (2006) Prevalence and characteristics of the polycys-tic ovary syndrome in overweight and obese women. Arch Intern Med 166:2081-2086
43. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, San Millán JL (2005) The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 90:6364- 6369. doi:10.1210/jc.2005-1490
44. Jayagopal V, Kilpatrick ES, Holding S, Jennings PE, Atkin SL (2005) Orlistat is as beneWcial as metformin in the treatment of polycystic ovarian syndrome. J Clin Endocrinol Metab 90:729- 733. doi:10.1210/jc.2004-0176
45. Sabuncu T, Harma M, Harma M, Nazligul Y, Kilic F (2003) Si-butramine has a positive eVect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome. Fertil Steril 80:1199-1204. doi:10.1016/S0015- 0282(03)02162-9
46. Legro RS, Castracane VD, KauVman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59:141-154
47. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN (2010) Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 162:193-212. doi:10.1530/EJE-09-0733
48. Franks S (2011) When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clin Endocrinol (Oxf) 74:148-151. doi:10.1111/j.1365-2265.2010.03934.x
49. Johnson N (2011) Metformin is a reasonable Wrst-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome-a meta-analysis of randomised trials. Aust N Z J Obstet Gynaecol 51:125-129. doi:10.1111/j.1479-828X. 2010.01274.x
50. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (1):CD003053. doi:10.1002/14651858.CD003053.pub4
51. Mauri D, Pavlidis N, Polyzos NP, Ioannidis JP (2006) Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst 98:1285-1291. doi:10.1093/jnci/djj357
52. Mitwally FM, Casper RF (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75:305-309. doi:10.1016/S0015-0282(00)01705-2
53. Casper RF, Mitwally MF (2006) Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 91:760-771. doi:10.1210/jc.2005-1923
54. Casper RF (2009) Letrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril 92:858-859. doi:10.1016/j.fertnstert.2007. 03.094
55. Pritts EA (2010) Letrozole for ovulation induction and controlled ovarian hyperstimulation. Curr Opin Obstet Gynecol 22:289-294. doi:10.1097/GCO. 0b013e32833beebf
56. Lee VC, Ledger W (2011) Aromatase inhibitors for ovulation induction and ovarian stimulation. Clin Endocrinol (Oxf) 74:537- 546. doi:10.1111/j.1365-2265. 2011.04006.x
57. He D, Jiang F (2011) Meta-analysis of letrozole versus clomi-phene citrate in polycystic ovary syndrome. Reprod Biomed Online 23:91-96. doi:10.1016/j.rbmo.2011.03.024
58. Yang MQ, Quan S, Li H, Song YL, Xing FQ (2008) EVect of two diVerent doses of letrozole in promoting ovulation in infertile women with polycystic ovarian syndrome. Nan Fang Yi Ke Da Xue Xue Bao 28:2060-2061
59. Ramezanzadeh F, Nasiri R, Sarafraz Yazdi M, Baghrei M (2011) A randomized trial of ovulation induction with two diVerent doses of letrozole in women with PCOS. Arch Gynecol Obstet 284:1029-1034. doi:10.1007/s00404-011-1951-5
60. Tredway DR, Schertz JC (2011) Anastrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril 95:1549-1551. doi:10.1016/j.fertnstert.2010.07.1094
61. Biljan MM, Hemmings R, Brassard N (2005) The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 84(suppl 1):S95
62. Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R (2007) Fetal safety of letrozole and clomiphene citrate for ovulation induction. J Obstet Gynaecol Can 29:668-671
63. Tulandi T, Martin J, Al-Fadhli R et al (2006) Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85:1761-1765. doi:10.1016/j.fertnstert.2006. 03.014
64. Badawy A, Shokeir T, Allam AF, Abdelhady H (2009) Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 88:187-191. doi:10.1080/00016340802638199
65. Felemban A, Lin Tan S, Tulandi T (2000) Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 73:266-269. doi:10.1016/S0015-0282(99)00534-8
66. Mercorio F, Mercorio A, Di Spiezio Sardo A, Barba GV, Pellicano M, Nappi C (2008) Evaluation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy. Fertil Steril 89:1229-1233. doi:10.1016/j.fertnstert.2007.05.009
67. Api M (2009) Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol Endocrinol 25:159-165. doi:10.1080/09513590802585605
68. Cleemann L, Lauszus FF, Trolle B (2004) Laparoscopic ovarian drilling as Wrst line of treatment in infertile women with polycystic ovary syndrome. Gynecol Endocrinol 18:138-143. doi:10.1080/09513590410001667869
69. Amer SA, Li TC, Metwally M, Emarh M, Ledger WL (2009) Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a Wrst-line method of ovulation induction in women with polycystic ovary syndrome. Hum Reprod 24:219-225. doi:10.1093/humrep/den325
70. Abu Hashim H, Foda O, Ghayaty E, Elawa A (2011) Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile? A randomized controlled trial. Arch Gynecol Obstet 284:1303-1309. doi:10.1007/s00404-011-1983-x
71. Tummon I, Gavrilova-Jordan L, Allemand MC, Session D (2005) Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obstet Gynecol Scand 84:611-616. doi:10.1111/j.0001-6349.2005.00788.x
72. Van Der Meer M, Hompes PG, De Boer JA, Schats R, Schoemaker J (1998) Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 83:423-426. doi:10.1210/jc.83.2.423
73. Cristello F, Cela V, Artini PG, Genazzani AR (2005) Therapeutic strategies for ovulation induction in infertile women with polycys-tic ovary syndrome. Gynecol Endocrinol 21:340-352. doi:10.1080/09513590500463360
74. Homburg R, Insler V (2002) Ovulation induction in perspective. Hum Reprod Update 8:449-462. doi:10.1093/humupd/8.5.449
75. Homburg R, Howles CM (1999) Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, reXections and reWnements. Hum Reprod Update 5:493- 499. doi:10.1093/humupd/5.5.493
76. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, Hamilton-Fairley D, Franks S (1996) Induction of ovula-tion with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81:3821-3824. doi:10.1210/jc.81.11.3821
77. Yarali H, Zeyneloglu HB (2004) Gonadotrophin treatment in patients with polycystic ovary syndrome. Reprod Biomed Online 8:528-537. doi:10.1016/S1472- 6483(10)61099-1
78. López E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J (2004) Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as Wrst line therapy. Reprod Biomed Online 9:382-390. doi:10.1016/S1472-6483(10)61273-4
79. Corfman RS, Ory SJ, Milad MP, Erickson LD, Bellevance TL, Ball GD (1993) A novel ovarian stimulation protocol for use with assisted reproductive technologies. Fertil Steril 60:864-870
80. Lu PY, Lee SH, Chen ALJ, Erickson LD, Atkinson EJ, Ory SJ (1996) Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility. Fertil Steril 65:583-587
81. Abu Hashim H, Bazeed M, Abd Elaal I (2012) Minimal stimulation or clomiphene citrate as Wrst line therapy in women with poly-cystic ovary syndrome: a randomized controlled trial. Gynecol Endocrinol. 28:87-90. doi:10.3109/09513590.2011.589924
82. Mukherjee S, Sharma S, Chakravarty BN (2010) Comparative evaluation of pregnancy outcome in gonadotrophin-clomiphene combination vs clomiphene alone in polycystic ovarian syndrome and unexplained infertility-a prospective clinical trial. J Hum Reprod Sci 3:80-84. doi:10.4103/0974-1208.69341
83. Aboulghar M, Baird DT, Collins J, ESHRE Capri Workshop Group et al (2009) Intrauterine insemination. Hum Reprod Update 15:265-277. doi:10.1093/humupd/ dmp003
84. Abdelkader AM, Yeh J (2009) The potential use of intrauterine insemination as a basic option for infertility: a review for technology-limited medical settings. Obstet Gynecol Int 2009:584837. doi:10.1155/2009/584837
85. Abu Hashim H, Ombar O, Abd Elaal I (2011) Intrauterine insemination versus timed intercourse with clomiphene citrate in polycystic ovary syndrome: a randomized controlled trial. Acta Obstet Gynecol Scand 90:344-350. doi:10.1111/j.1600-0412.2010.01063.x